Advertisement

Topics

"Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy" Drugs and Medication Database

03:52 EDT 25th March 2019 | BioPortfolio

Here are the most relevant "Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy" Drugs and Medications that we have found in our database.

More Information about "Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy" on BioPortfolio

We have published hundreds of Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy news stories on BioPortfolio along with dozens of Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy Clinical Trials and PubMed Articles about Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy Companies in our database. You can also find out about relevant Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy Drugs and Medications on this site too.

Showing "Efficacy Trial Comparing ZD6474 With Erlotinib NSCLC After" Drugs and Medications 1–25 of 37

Probably Relevant

Tarceva [physicians total care, inc.]

These highlights do not include all the information needed to use TARCEVA safely and effectively. See full prescribing information for TARCEVA. TARCEVA (erlotinib hydrochloride) tablet for oral use Initial U.S. Approval: 2004

Possibly Relevant

Tarceva [genentech, inc.]

These highlights do not include all the information needed to use TARCEVA safely and effectively. See full prescribing information for TARCEVA.TARCEVA (erlotinib) tablets, for oral useInitial U.S. Approval: 2004

Vinorelbine [hospira, inc.]

These highlights do not include all the information needed to use VINORELBINE INJECTION safely and effectively. See full prescribing information for VINORELBINE INJECTION.VINORELBINE INJECTION, USP, injection, for intravenous useInitial U.S. Approval: 199

Navelbine [pierre fabre pharmaceuticals, inc.]

These highlights do not include all the information needed to use NAVELBINE safely and effectively. See full prescribing information for NAVELBINE. NAVELBINE® (vinorelbine) injection, for intravenous use Initial U.S. Approval: 1994

Vinorelbine [actavis pharma, inc.]

These highlights do not include all the information needed to use vinorelbine injection safely and effectively. See full prescribing information for vinorelbine injection. VINORELBINE injection, USP, for intravenous use Initial U.S. Approval: 1994

Gilotrif [boehringer ingelheim pharmaceuticals, inc.]

These highlights do not include all the information needed to use GILOTRIF safely and effectively. See full prescribing information for GILOTRIF. GILOTRIF (afatinib) tablets, for oral useInitial U.S. Approval: 2013

Iressa [astrazeneca pharmaceuticals lp]

These highlights do not include all the information needed to use IRESSA safely and effectively. See full prescribing information for IRESSAIRESSA(gefitinib) tablets for oral useInitial U.S. Approval: 2015

Keytruda [merck sharp & dohme corp.]

These highlights do not include all the information needed to use KEYTRUDA safely and effectively. See full prescribing information for KEYTRUDA. KEYTRUDA(pembrolizumab) for injection, for intravenous use KEYTRUDA(pembrolizumab) injection, for intravenous

Xalkori [pfizer laboratories div pfizer inc]

These highlights do not include all the information needed to use XALKORI safely and effectively. See full prescribing information for XALKORI. XALKORI (crizotinib) capsules, for oral use Initial U.S. Approval: 2011

Tagrisso [astrazeneca pharmaceuticals lp]

These highlights do not include all the information needed to use TAGRISSO safely and effectively. See full prescribing information for TAGRISSO. TAGRISSO (osimertinib) tablets, for oral useInitial U.S. Approval: 2015

Cyramza [eli lilly and company]

These highlights do not include all the information needed to use CYRAMZA safely and effectively. See full prescribing information for CYRAMZA.CYRAMZA (ramucirumab) injection, for intravenous useInitial U.S. Approval: 2014

Abraxane [abraxis bioscience, llc]

These highlights do not include all the information needed to use ABRAXANE safely and effectively.  See full prescribing information for ABRAXANE. ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension)(albumin-b

Alimta [eli lilly and company]

These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for ALIMTA.ALIMTA (pemetrexed for injection), for Intravenous UseInitial U.S. Approval: 2004

Tecentriq [genentech, inc.]

These highlights do not include all the information needed to use TECENTRIQ safely and effectively. See full prescribing information for TECENTRIQ. TECENTRIQ (atezolizumab) injection, for intravenous useInitial U.S. Approval: 2016

Mvasi [amgen inc]

These highlights do not include all the information needed to use MVASI safely and effectively. See full prescribing information for MVASI .     MVASI (bevacizumab-awwb ) Solution for intravenous infusion Initial U.S. Approval: 2017 MVASI (bevacizumab-

Tafinlar [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use TAFINLAR safely and effectively. See full prescribing information for TAFINLAR . TAFINLAR   ( dabrafenib ) capsules ,   for oral use Initial U.S. Approval: 2013

Docetaxel [x-gen pharmaceuticals, inc.]

These highlights do not include all the information needed to use DOCETAXEL INJECTION USP (Injection Concentrate) safely and effectively. See full prescribing information for DOCETAXEL INJECTION USP (Injection Concentrate). DOCETAXEL Injection (Injection

Alecensa [genentech, inc.]

These highlights do not include all the information needed to use ALECENSA safely and effectively. See full prescribing information for ALECENSA. ALECENSA (alectinib) capsules, for oral useInitial U.S. Approval: 2015

Vizimpro [u.s. pharmaceuticals]

These highlights do not include all the information needed to use VIZIMPRO safely and effectively. See full prescribing information for VIZIMPRO. VIZIMPRO (dacomitinib) tablets, for oral use Initial U.S. Approval: 2018

Vizimpro [pfizer laboratories div pfizer inc]

These highlights do not include all the information needed to use VIZIMPRO safely and effectively. See full prescribing information for VIZIMPRO. VIZIMPRO (dacomitinib) tablets, for oral use Initial U.S. Approval: 2018

Infugem [sun pharmaceutical industries, inc.]

These highlights do not include all the information needed to use INFUGEM safely and effectively. See full prescribing information for INFUGEM.   INFUGEM (gemcitabine in sodium chloride injection), for intravenous use Initial U.S. Approval: 1996  

Docetaxel [actavis pharma, inc.]

These highlights do not include all the information needed to use DOCETAXEL INJECTION safely and effectively. See full prescribing information for DOCETAXEL INJECTION. DOCETAXEL injection, for intravenous use Initial U.S. Approval: 1996

Docetaxel [mylan institutional llc]

These highlights do not include all the information needed to use DOCETAXEL INJECTION safely and effectively. See full prescribing information for DOCETAXEL INJECTION. DOCETAXEL injection, for intravenous use Initial U.S. Approval: 1996

Docetaxel [mylan institutional llc]

These highlights do not include all the information needed to use DOCETAXEL INJECTION safely and effectively. See full prescribing information for DOCETAXEL INJECTION. DOCETAXEL INJECTION, for intravenous use Initial U.S. Approval: 1996

Docetaxel [mylan institutional llc]

These highlights do not include all the information needed to use DOCETAXEL INJECTION safely and effectively. See full prescribing information for DOCETAXEL INJECTION. DOCETAXEL injection, for intravenous use Initial U.S. Approval: 1996



Advertisement
Quick Search
Advertisement
Advertisement